Galux Alternatives & Competitors
11 companies similar to Galux — Biotech leveraging AI, physics, and chemistry to design novel drugs against attr...
Companies similar to Galux
Genesis Molecular AI
Unifying AI and Biotech to accelerate the discovery of new medicines
San Mateo, United States
Accutar Biotech
Employ AI to Revolutionize Drug Discovery
Brooklyn, United States
Celeris Therapeutics
The PIC Engineering Company.
Menlo Park, United States
1910 Genetics
Advancing small and large molecule drug discovery with a multimodal AI platform powered by...
Boston, United States
Track all Galux competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
PharmCADD
PharmCADD is a company designed to accelerate drug discovery using technologies of AI and...
Busan, Korea South
CHARM Therapeutics
Protein-ligand intelligence to deliver next generation small molecule therapeutics
London, United Kingdom
Meddenovo Drug Design
Meddenovo offers a unique blend of AI technologies and molecular modeling to design cyclic...
Lyon, France
DeepCure
Reimagining small molecule therapies for immune diseases
Boston, United States
Insilico Medicine
#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLM...
Boston, United States
About Galux
Galux, founded in 2020, is at the forefront of biotechnology, leveraging the synergy of AI, physics, and chemistry. Based in South Korea, their mission is encapsulated in their slogan: "Biotech leveraging AI, physics, and chemistry to design novel drugs against attractive targets." The company has a strong technologica...
AI-powered protein design, Development of therapeutic antibodies, Collaborative drug innovation projects
Biopharmaceutical companies, Research institutions in drug discovery, Healthcare and life sciences researchers
AI-Based Drug Design, Molecular Design Technology, Protein Structure Prediction, Protein-Protein Interaction Prediction, Protein-Ligand Interaction Prediction, Drug Discovery, Novel Therapeutics, Incurable Diseases, Rare Diseases, Neural Networks, Biological Drugs, Chemical Drugs, Small Molecule Drugs, Large Molecule Drugs
B2B, Platform, SaaS
Project Based, Licensing, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Galux and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Galux on 15 Jun 2026. The 11 companies listed here were last checked between 29 May 2025 and 22 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
